Functional estrogen receptors in the mitochondria of breast cancer cells

Molecular Biology of the Cell

Volumn 17, Issue 5, 2006, Pages 2125-2137

  Pedram, Ali ^a,b   Razandi, Mahnaz ^a,b   Wallace, Douglas C ^c   Levin, Ellis R ^a,c  

^a VA LONG BEACH HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CELL NUCLEUS RECEPTOR; CYTOCHROME C; ESTRADIOL; ESTROGEN RECEPTOR; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; MANGANESE SUPEROXIDE DISMUTASE; PROTEIN BAX; PROTEIN KINASE C DELTA; REACTIVE OXYGEN METABOLITE; STEROID HORMONE; STRESS ACTIVATED PROTEIN KINASE;

ANIMAL CELL; APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL ORGANELLE; CELL STRAIN MCF 7; CELL SURVIVAL; CONTROLLED STUDY; CYTOPLASM; ENDOTHELIUM CELL; ENZYME ACTIVITY; ENZYME REGULATION; ENZYME RELEASE; HUMAN; HUMAN CELL; MEMBRANE POTENTIAL; MITOCHONDRIAL MEMBRANE; MOUSE; NONHUMAN; OLIGOMERIZATION; PRIORITY JOURNAL; PROTEIN LOCALIZATION; RECEPTOR AFFINITY; ULTRAVIOLET A RADIATION;

BCL-2-ASSOCIATED X PROTEIN; BREAST NEOPLASMS; CELL LINE, TUMOR; CELL MEMBRANE; CYTOCHROMES C; ESTRADIOL; ESTROGENS; HUMANS; JNK MITOGEN-ACTIVATED PROTEIN KINASES; MITOCHONDRIA; PROTEIN TRANSPORT; PROTO-ONCOGENE PROTEINS C-AKT; REACTIVE OXYGEN SPECIES; RECEPTORS, ESTROGEN;

EID: 33744514462     PISSN: 10591524     EISSN: None     Source Type: Journal    
DOI: 10.1091/mbc.E05-11-1013     Document Type: Article

References (60)

1. Aslan, M., and Ozben, T. (2003). Oxidants in receptor tyrosine kinase signal transduction pathways. Antioxid. Redox. Signal 5, 781-788.
2. Benhar, M., Engelberg, D., and Levitzki, A. (2002). ROS, stress-activated kinases and stress signaling in cancer. EMBO Rep. 3, 420-425.
3. Borras, C., Sastre, J., Garcia-Sala, D., Lloret, A., Pallardo, F. V., and Vina, J. (2003). Mitochondria from females exhibit higher antioxidant gene expression and lower oxidative damage than males. Free Radic. Biol. Med. 34, 546-552.
4. Borras, C., Gambini, J., Gomez-Cabrera, M. C., Sastre, J., Pallardo, F. V., Mann, G. E., and Vina, J. (2005). 17beta-oestradiol up-regulates longevity-related, antioxidant enzyme expression via the ERK1 and ERK2[MAPK]/NFkappaB cascade. Aging Cell 4, 113-118.
5. Brodie, C., and Blumberg, P. M. (2003). Regulation of cell apoptosis by protein kinase c delta. Apoptosis 8, 19-27.
6. Chapman, K. E., Sinclair, S. E., Zhuang, D., Hassid, A., Desai, L., and Waters, C. M. (2005). Cyclic mechanical strain increases reactive oxygen species production in pulmonary epithelial cells. Am. J. Physiol. Lung Cell Mol. Physiol. 289, L834-L841.
7. Chen, J. Q., Delannoy, M., Cooke, C., and Yager, J. D. (2004). Mitochondrial localization of ERα and ERβ in human MCF-7 cells. Am. J. Physiol. Endocrinol. Metab. 28, E1011-E1022.
8. Curtin, J. F., Donovan, M., and Cotter, T. H. (2002). Regulation and measurement of oxidative stress response in apoptosis. J. Immunol. Methods 265, 49-72.
9. Danial, N. K., and Korsmeyer, S. J. (2004). Cell death: critical control points. Cell 116, 205-219.
10. Dejean, L. M. et al. (2005). Oligomeric Bax is a component of the putative cytochrome c release channel MAC, mitochondrial apoptosis-induced channel. Mol. Biol. Cell 16, 2424-2432.
11. Ding, L., Wang, H., Lang, W., and Xiao, L. (2002). PKC-epsilon promotes survival of lung cancer cells by suppressing apoptosis through dysregulation of the mitochondrial caspase pathway. J. Biol. Chem. 277, 35305-35313.
12. Dong, L., Wang, W., Wang, F., Stoner, M., Reed, J. C., Harigai, M., Samudio, I., Kladde, M. P., Vyhlidal, C., and Safe, S. (1999). Mechanisms of transcriptional activation of bcl-2 gene expression by 17beta-estradiol in breast cancer cells. J. Biol. Chem. 274, 32099-32107.
13. Felty, Q., Singh, K. P., and Roy, D. (2005). Estrogen-induced G(1)/S transition of G(0)-arrested estrogen-dependent breast cancer cells is regulated by mitochondrial oxidant signaling. Oncogene 24, 4883-4893.
14. Fernando, R. I., and Wimalasena, J. (2004). Estradiol abrogates apoptosis in breast cancer cells through inactivation of BAD: Ras-dependent nongenomic pathways requiring signaling through ERK and Akt. Mol. Biol. Cell 15, 3266-3284.
15. Finkel, T., and Holbrook, N. J. (2000). Oxidants, oxidative stress and the biology of ageing. Nature 408, 239-247.
16. Forster, C., Kietz, S., Hultenby, K., Warner, M., and Gustafsson, J. A. (2004). Characterization of the ERbeta-/-mouse heart. Proc. Natl. Acad. Sci. USA 101, 14234-14239.
17. Fuqua, S. A., and Cui, Y. (2004). Estrogen and progesterone receptor isoforms: clinical significance in breast cancer. Breast Cancer Res. Treat. 87, S3-10.
18. Gray, M. O., Zhou, H. Z., Schafhalter-Zoppoth, I., Zhu, P., Mochly-Rosen, D., and Messing, R. O. (2004). Preservation of base-line hemodynamic function and loss of inducible cardioprotection in adult mice lacking PKC epsilon. J. Biol. Chem. 279, 3596-3604.
19. Green, D. G. (2005). Apoptotic pathways: ten minutes to dead. Cell 121, 671-674.
20. Gross, A., Jockel, J., Wei, M. C., and Korsmeyer, S. J. (1998). Enforced dimerization of BAX results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J. 17, 3878-3885.
21. Halliwell, B. (1999). Antioxidant defence mechanisms: from the beginning to the end (of the beginning). Free Radic. Res. 31, 261-272.
22. Harrington, W. R., Sheng, S., Barnett, D. H., Petz, L. N., Katzenellenbogen, J. A., and Katzenellenbogen, B. S. (2003). Activities of estrogen receptor alpha-and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression. Mol. Cell Endocrinol. 206, 13-22.
23. Huang, P., Feng, L., Oldham, E. A., Keating, M. J., and Plunkett, W. (2000). Superoxide dismutase as a target for the selective killing of cancer cells. Nature 407, 390-395.
24. James, A. M., Cocheme, H. M., Smith, R. A., and Murphy, M. P. (2005). Interactions of mitochondria-targeted and untargeted ubiquinones with the mitochondrial respiratory chain and reactive oxygen species. Implications for the use of exogenous ubiquinones as therapies and experimental tools. J. Biol. Chem. 280, 21295-21312.
25. Jensen, E. V., and Jacobson, H. I. (1962). Basic guides to the mechanism of estrogen action. Rec. Prog. Horm. Res. 18, 387-414.
26. Jurgensmeier, J. M., Xie, Z., Deveraux, Q., Ellerby, L., Bredesen, D., and Reed, J. C. (1998). Bax directly induces release of cytochrome c from isolated mitochondria. Proc. Natl. Acad. Sci. USA 95, 4997-5002.
27. Kamata, H., Honda, S., Maeda, S., Chang, L., Hirata, H., and Karin, M. (2005). Reactive oxygen species promote TNFalpha-induced death and sustained JNK activation by inhibiting MAP kinase phosphatases. Cell 120, 649-661.
28. Kelso, G. F., Porteous, C. M., Coulter, C. V., Hughes, G., Porteous, W. K., Ledgerwood, E. C., Smith, R. A., and Murphy, M. P. (2001). Selective targeting of a redox-active ubiquinone to mitochondria within cells: antioxidant and antiapoptotic properties. J. Biol. Chem. 276, 4588-4596.
29. Kipp, J. L., and Ramirez, V. D. (2001). Effect of esrradiol, diethylstilbestrol, and resveratrol on F0F1-ATPase activity from mitochondrial preparations of rat heart, liver, and brain. Endocrine 15, 165-175.
30. Kroemer, G. (2003). Mitochondrial control of apoptosis: an introduction. Biochem. Biophys. Res. Commun. 304, 433-435.
31. Levin, E. R. (2001). Cell localization, physiology and nongenomic actions of estrogen receptors. J. Appl. Physiol. 91, 1860-1867.
32. Levin, E. R. (2005). Integration of the extra-nuclear and nuclear actions of estrogen. Mol. Endocrinol. 19, 1951-1959.
33. Lopez, G. N., Webb, P., Shinsako, J. H., Baxter, J. D., Greene, G., and Kushner, P. J. (1999). Titration by estrogen receptor activation function-2 of targets that are downstream from coactivators. Mol. Endocrinol. 13, 897-909.
34. Majumder, P. K., Mishra, N. C., Sun, X., Bharti, A., Kharbanda, S., Saxena, S., and Kufe, D. (2001). Targeting of PKC delta to mitochondria in the oxidative stress response. Cell Growth Differ. 12, 465-470.
35. Mandlekar, S., and Kong, A. N. (2001). Mechanisms of tamoxifen-induced apoptosis. Apoptosis 6, 469-477.
36. Marquez, D. C., and Pietras, R. J. (2001). Membrane-associated binding sites for estrogen contribute to growth regulation of human breast cancer cells. Oncogene 20, 5420-5430.
37. McJilton, M. A. et al. (2003). Protein kinase Cepsilon interacts with Bax and promotes survival of human prostate cancer cells. Oncogene 22, 7958-7968.
38. Mingo-Sion, A. M., Marietta, P. M., Koller, E., Wolf, D. M., and Van Den Berg, C. L. (2004). Inhibition of JNK reduces G2/M transit independent of p53, leading to endoreduplication, decreased proliferation, and apoptosis in breast cancer cells. Oncogene 23, 596-604.
39. Morkuniene, R., Akabsone, A., and Borutaite, V. (2002). Estrogens prevent calcium-induced release of cytochrome c from heart mitochondria. FEBS Lett. 521, 53-56.
40. Murriel, C. L., and Mochly-Rosen, D. (2003). Opposing roles of delta and epsilon PKC in cardiac ischemia and reperfusion: targeting the apoptotic machinery. Arch. Biochem. Biophys. 15, 246-254.
41. Ohnishi, S. T., Ohnishi, T., Muranaka, S., Fujita, H., Kimura, H., Uemura, K., Yoshida, K., and Utsumi, K. (2005). A possible site of superoxide generation in the complex I segment of rat heart mitochondria. J. Bioenerg. Biomembr. 37, 1-15.
42. Petros, J. A. et al. (2005). mtDNA mutations increase tumorigenicity in prostate cancer. Proc. Natl. Acad. Sci. USA 102, 719-724.
43. 2 by catalase inhibits the proliferation of HER-2/Neu-transformed rat-1 fibroblasts through the induction of a stress response. J. Biol. Chem. 276, 9558-9564.
44. Razandi, M., Pedram, A., and Levin, E. R. (2000). Plasma membrane estrogen receptors signal to anti-apoptosis in breast cancer. Mol. Endocrinol. 14, 1434-1447.
45. Razandi, M., Alton, G., Pedram, A., Ghonshani, S., Webb, D., and Levin, E. R. (2003). Identification of a structural determinant for the membrane localization of ERα. Mol. Cell Biol. 23, 1633-1646.
46. Razandi, M., Pedram, A., Merchenthaler, I., Greene, G. L., and Levin, E. R. (2004a). Plasma membrane estrogen receptors exist and function as dimers. Mol. Endocrinol. 18, 2854-2865.
47. Razandi, M., Pedram, A., Rosen, E., and Levin, E. R. (2004b). BRCA1 inhibits membrane estrogen and growth factor receptor signaling to cell proliferation in breast cancer. Mol. Cell Biol. 24, 5900-5913.
48. Sato, H., Sato, M., Kanai, H., Uchiyama, T., Iso, T., Ohyama, Y., Sakamoto, H., Tamura, J., Nagai, R., and Kurabayashi, M. (2005). Mitochondrial reactive oxygen species and c-Src play a critical role in hypoxic response in vascular smooth muscle cells. Cardiovasc. Res. 67, 714-722.
49. Steinberg, S. F. (2004). Distinctive activation mechanisms and functions for protein kinase Cdelta. Biochem. J. 384, 449-459.
50. Stirone, C., Duckles, S. P., Krause, D. N., and Procaccio, V. (2005). Estrogen increases mitochondrial efficiency and reduces oxidative stress in cerebral blood vessels. Mol. Pharmacol. 68, 959-965.
51. Strehlow, K., Rotter, S., Wassmann, S., Adam, O., Grohe, C., Laufs, K., Bohm, M., and Nickenig, G. (2003). Modulation of antioxidant enzyme expression and function by estrogen. Circ. Res. 93, 170-177.
52. Trounce, I., Kim, Y. L., Jun, A. S., and Wallace, D. C. (1996). Assessment of mitochondrial oxidative phosphorylation in patient muscle biopsies, lymphoblasts, and transmitochondrial cell lines. Methods Enzymol. 264, 484-509.
53. Tsuruta, F., Masuyama, N., and Gotoh, Y. (2002). The phosphatidylinositol 3-kinase (PI3K)-Akt pathway suppresses Bax translocation to mitochondria. J. Biol. Chem. 277, 14040-14047.
54. Tsuruta, F., Sunayama, J., Mori, Y., Hattori, S., Shimizu, S., Tsujimoto, Y., Yoshioka, K., Masuyama, N., and Gotoh, Y. (2004). JNK promotes Bax translocation to mitochondria through phosphorylation of 14-3-3 proteins. EMBO J. 23, 1889-1899.
55. Wang, X. (2001). The expanding role of mitochondria in apoptosis. Genes Dev. 15, 2922-2933.
56. Wang, X., Simpkins, J. W., Dykens, J. A., and Cammarata, P. R. (2003). Oxidative damage to human lens epithelial cells in culture: estrogen protection of mitochondrial potential, ATP, and cell viability. Invest. Ophthalmol. Vis. Sci. 44, 2067-2075.
57. Wecksler, W. R., and Norman, A. W. (1999). An hydroxylapatite batch assay for the quantitation of 1alpha,25-dihydroxyvitamin D3-receptor complexes. Annal. Biochem. 92, 314-323.
58. Xia, F., and Powell, S. N. (2002). The molecular basis of radiosensitivity and chemosensitivity in the treatment of breast cancer. Semin. Radiat. Oncol. 12, 296-304.
59. Yang, S.-H. et al. (2004). Mitochondrial localization of estrogen receptor beta. Proc. Natl. Acad. Sci. USA 101, 4130-4135.
60. Yu, D., Jing, T., Liu, B., Yao, J., Tan, M., McDonnell, T. J., and Hung, M. C. (1998). Overexpression of ErbB2 blocks taxol-induced apoptosis by upregulation of p21Cip1, which inhibits p34Cdc2 kinase. Mol. Cell 2, 581-591.